Skip to main content

Day: June 27, 2024

Nexans and SNCF Réseau revolutionize rail safety with an innovative superconducting fault current limiter

_PRESS RELEASE_Nexans and SNCF Réseau are once again joining forces in superconductivity to increase the safety and reliability of the rail network. Developed by Nexans and installed by SNCF Réseau, the superconducting fault current limiter (SFCL) is a world first on the rail market. It limits disruptions to the power supply of the rail network using a standalone system to reduce short-circuit currents. Designed to supply power for trains in the Belfort area (Burgundy-Franche-Comté region in France), this innovative limiter improves the availability of electrical installations.Paris, June 27, 2024 – Nexans, a leader in the design and manufacture of cable systems and services, is forming a unique partnership with SNCF Réseau, infrastructure manager of the French rail network, to deploy a superconducting fault current limiter....

Continue reading

GXO recognized by Ex-Forces in Business for support of British veterans and reservists

Colin – British Ex-Forces in BusinessColin Martin, a QHSE Manager at GXO, is also nominated for reservist of the yearThe UK’s leading logistics firm has been nominated for the Employer of the Year Award for the second year running by Ex-Forces in Business Colin Martin, a QHSE Manager at GXO, is also nominated for reservist of the year GXO ranked among the Top 50 Employers of Veterans in 2024 LONDON, U.K., June 27, 2024 (GLOBE NEWSWIRE) — GXO Logistics, Inc. (NYSE: GXO), the world’s largest pure-play contract logistics provider, announced today that it has been nominated for two British Ex-Forces in Business Awards – the world’s largest celebration of veterans in second careers. GXO in the UK&I has been nominated by Ex-Forces in Business as Employer of the Year for the second year running, for its commitment...

Continue reading

Update regarding Debt Funding from A & T Investments SARL

Vast Resources plc / Ticker: VAST / Index: AIM / Sector: Mining 27 June 2024 Vast Resources plc(‘Vast’ or the ‘Company’) Update regarding Debt Funding from A & T Investments SARL (“Alpha”)(the “Debt Facility”) Vast Resources plc, the AIM-listed mining company, announces that it has received a Notice of Acceleration and Enforcement in relation to the Debt Facility (the “Notice”). The Notice given is to the effect that if the outstanding debt of $5,820,000 (the “Debt”) is not repaid in full by 26 September 2024 it will then enforce the security given to Alpha by a third party which party would in turn have recourse to Vast. At the time the third party security was provided, the asset was valued at more than the debt due to Alpha. The Notice also declares that the Debt be immediately due and payable by Vast and is thereby demanded. Alpha...

Continue reading

Advantest’s VOICE 2024 Draws Record Attendance in San Diego

Annual Developer Conference Hosts Major Semiconductor Companies for Dialogue on Latest Technologies and Industry TrendsVOICE 2024Attendees mingling at the Partners’ Expo.VOICE 2024VOICE Chairperson Linda Haenel addressing the crowd during the General Session.TOKYO, June 27, 2024 (GLOBE NEWSWIRE) — Leading semiconductor test equipment supplier Advantest Corporation (TSE: 6857) concluded a successful VOICE 2024 at the Hilton La Jolla Torrey Pines in San Diego, California. The event was held on June 3-5 and drew a record-high attendance of over 400 attendees, the majority of whom were Advantest customers and industry partners. This year’s VOICE event coincided with Advantest’s 70th anniversary, and the company was pleased to commemorate this milestone with longstanding customers and industry partners. The...

Continue reading

Quadient S.A. – 2023 dividend payment timeline

Quadient – 2023 dividend payment timeline Paris, 27 June 2024, Quadient Annual General Meeting, held on 14 June 2024, approved the amount of dividends for financial year 2023. The amount of dividends is €0.65 per share and will be paid in cash, in one instalment, on 7 August 2024. The dividend payment timeline will be as follows:Ex-dividend: 5 August 2024; Record date: 6 August 2024; Payment date: 7 August 2024.*** About Quadient® Quadient is a global automation platform provider powering secure and sustainable business connections through digital and physical channels. Quadient supports businesses of all sizes in their digital transformation and growth journey, unlocking operational efficiency and creating meaningful customer experiences. Listed in compartment B of Euronext Paris (QDT) and part of the CAC® Mid & Small and...

Continue reading

Completion of the Second Tranche of Stellantis 2024 Share Buyback Program and Weekly Report (June 21-26, 2024)

Completion of the Second Tranche of Stellantis 2024 Share Buyback Program and Weekly Report (June 21-26, 2024) AMSTERDAM, June 27, 2024 – Stellantis N.V. (“Stellantis” or the “Company”) announced today that its Second Tranche of the 2024 Share Buyback Program announced on May 23, 2024, covering up to €1 billion to be executed in the open market during the period between May 23, 2024 and August 30, 2024, has been completed. Since May 23, 2024 up to and including June 26, 2024, the Company has purchased a total of 51,025,628 common shares for a total consideration of € 1,000,000,120. During the period between June 21 up to and including June 26, 2024 the Company has repurchased the following common shares:Date Number of Shares Repurchased Average Market Purchase Price in € per share Repurchased Volume in € (excluding fees) Venues...

Continue reading

Vigil Neuroscience Announces $40 Million Strategic Investment from Sanofi

– Sanofi to invest $40 million at an as-converted price of $7.44 per share of common stock- – Sanofi to receive an exclusive right of first negotiation for license of Company’s small molecule TREM2 agonist program, including VG-3927, currently in phase 1 clinical studies – – Company expects proceeds to extend cash runway into 2026 – WATERTOWN, Mass., June 27, 2024 (GLOBE NEWSWIRE) — Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, is pleased to announce that Sanofi (Nasdaq: SNY) has made a $40 million strategic investment in the Company at an as-converted price of $7.44 per share of common stock. Sanofi will purchase 537,634 of the Company’s Series A non-voting preferred shares,...

Continue reading

Technip Energies acquires technology from Shell to accelerate bio-polyester production

Technip Energies – Sustainable ChemistryTechnip Energies – Sustainable ChemistryThe acquisition of glycol purification technology will accelerate Technip Energies’ Bio-2-GlycolsTM commercialization. Technip Energies (PARIS:TE) and Shell Catalysts & Technologies announce a technology transfer agreement which accelerates the commercialization of Technip Energies’ Bio-2-GlycolsTM technology for bio-based Mono Ethylene Glycol (MEG) production from glucose. MEG is traditionally produced using fossil-based feedstock to make various types of polyesters for packaging materials, such as plastic bottles, and in clothing apparel. With this acquisition, Technip Energies intends to offer a bio-based polyester solution by replacing fossil-based feedstock. By using a bio-sourced monomer, the Bio-2-GlycolsTM technology allows...

Continue reading

TGS Announces New Mutli-Client Onshore 3D Seismic Survey In The Appalachian Basin

TGS-Birmingham3D_PR_C65329TGS New Mutli-Client Onshore 3D Seismic Survey In The Appalachian BasinOSLO, Norway (27 June 2024) – TGS, a global leader in energy data and intelligence, today announced a new multi-client onshore 3D seismic survey, Birmingham 3D. The 206 KM2 survey is strategically located on the western flank of the Appalachian Basin, aligning with the most prospective trend of the Utica-Point Pleasant formation and Clinton sands. Birmingham 3D will target multiple exploration zones, including the Ordovician Trenton and Black River, Cambrian reservoirs, Ordovician Utica/Point Pleasant and Silurian Clinton sands. This area is characterized by world-class source rocks in the Devonian Marcellus and Ordovician Utica formations. Birmingham sits just up-dip of the Point Pleasant – Utica condensate and light oil trend imaged...

Continue reading

Roche expands access to cervical cancer screening tools with two new WHO prequalification designations, including HPV self-collection

The World Health Organization (WHO) has awarded Roche’s human papillomavirus (HPV) test prequalification designations for use on the cobas 5800 System and for self-collected samples on the cobas 5800, 6800 and 8800 Systems. These designations build upon last June’s WHO prequalification that included the cobas HPV test for use on the cobas 6800 and 8800 Systems. WHO prequalification enables low- and middle-income countries (LMICs) to use Roche HPV screening solutions, including self-collection, in their national cervical cancer elimination programs, which will greatly increase access. Every year, over 600,000 women worldwide are diagnosed with cervical cancer and over 340,000 die from this preventable disease, caused by HPV infection. Nine out of 10 women who die from cervical cancer live in LMICs.1Basel, 27 June 2024 –...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.